Tag: AstraZeneca
AstraZeneca Pharma India receives CDSCO approval for Durvalumab
The drug is targeted at the patients with Unresectable Hepatocellular Carcinoma (uHCC)
AstraZeneca gets CDSCO nod for Datopotamab Deruxtecan to treat Metastatic Breast...
The approval reflects AstraZeneca’s focus on bringing to life-changing medicines at a rapid pace and marks its second antibody–drug conjugate (ADC) approval in India
AstraZeneca and Sun Pharma partner to help patients living with Hyperkalaemia...
This exclusive agreement is aimed at further accelerating availability of SZC, an innovative and highly effective treatment for Hyperkalaemia to more patients across India
AstraZeneca secures CDSCO approval for expanded use of Trastuzumab Deruxtecan in...
This marks the first and only antibody drug conjugate (ADC) in India with a tumour-agnostic indication, representing a significant advancement in precision oncology
AstraZeneca India launches Eculizumab, first anti-complement therapy for aHUS & PNH
Both aHUS and PNH are ultra-rare, life-threatening disorders caused by chronic, uncontrolled activation of the complement system, leading to severe complications in blood and kidney health
AstraZeneca announces third investment of Rs 176 crore in India
This commitment comes on the sidelines of Tamil Nadu Chief Minister visit to United Kingdom and aims to boost AstraZeneca’s Global Innovation & Technology Centre in Chennai focused on advancing technology & innovation efforts in healthcare
Goa govt expands AI-powered lung cancer screening with Qure.ai & AstraZeneca,...
This landmark decision supports affordability of high-cost therapies, starting with lung cancer and will continue to cover rare and complex non-communicable diseases across the state, making healthcare accessible to all
A new era for lung cancer detection: AI-enabled risk assessment reaches...
The AI-enabled CXRs revealed important findings, including lung nodules at high risk for cancer in nearly 50,000 people – prompting their referral for further testing and possible diagnosis
LuNGS Alliance launches free lung NGS biomarker testing for lung cancer...
An Initiative by Cancer Research and Statistic Foundation, Supported by AstraZeneca, Pfizer & Roche and lab partner 4baseCare
AstraZeneca India launches Trastuzumab deruxtecan for HER-2 positive metastatic breast cancer...
Developed in collaboration with Daiichi Sankyo, Trastuzumab deruxtecan is a specifically engineered HER2-directed antibody drug conjugate